LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Synthesis and Biological Evaluation of Some Novel Bis-Thiadiazoles as Antimicrobial and Antitumor Agents

Photo by trnavskauni from unsplash

Abstract A novel series of bis(1,3,4-thiadiazole) derivatives were synthesized as a sole product in one step methodology by reaction of bis-hydrazonoylchloride 3 with many of hydrazinecarbodithioate derivatives 2a–e, 6a,b, and… Click to show full abstract

Abstract A novel series of bis(1,3,4-thiadiazole) derivatives were synthesized as a sole product in one step methodology by reaction of bis-hydrazonoylchloride 3 with many of hydrazinecarbodithioate derivatives 2a–e, 6a,b, and 8a–e. We discuss the mechanisms of the reactions studied and use elemental and spectral data to identify the assigned structure for each of the new products. This research aimed at synthesizing a novel series of derivatives of bis-thiadiazoles and investigating their antimicrobial and anticancer activity. The results showed that compound 6b was the most efficient synthesized antimicrobial compound. Moreover Compounds 8c, 10d, 6b, and 8d were the most active (IC50 values of 0.37 ± 0.15, 0.93 ± 0.32, 1.03 ± 0.45, and 3.52 ± 0.43 µg/mL, respectively) against human breast carcinoma cell line (MCF-7) and compounds 8c, 10d, 6b, and 8d were the most active (IC50 value of 0.38 ± 0.12, 0.88 ± 0.46, 2.15 ± 0.16, and 2.47 ± 0.44 µg/mL, respectively) against the human hepatocellular carcinoma cell line (HepG-2). Graphical Abstract

Keywords: evaluation novel; bis thiadiazoles; biological evaluation; novel bis; bis; synthesis biological

Journal Title: Polycyclic Aromatic Compounds
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.